Although worldwide adult mortality rates have been dropping overall for the past four decades, the gap between men and women, who have lower mortality risk, has widened, researchers found.
No Comments »
Filed under: General Health News
Johnson & Johnson has agreed to pay $81 million to settle charges that it improperly marketed its epilepsy drug topiramate (Topamax).
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — States have until the end of day Friday to inform the Department of Health and Human Services whether they want to run their own temporary high-risk insurance pools established by the new healthcare reform law, or whether they want the federal government to do it for them.
No Comments »
Filed under: General Health News
Critically ill patients who have no health insurance are less likely to be admitted to a hospital, receive fewer critical care services, and are more likely to die, an official review from the American Thoracic Society affirmed.
No Comments »
Filed under: General Health News
MINNEAPOLIS (MedPage Today) — Healthcare reform in Massachusetts appears to have increased the number of minorities receiving some surgical procedures, researchers say.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA today approved the immunotherapeutic agent sipuleucel-T (Provenge) for the treatment of advanced prostate cancer, almost three years after the agency rejected an advisory group’s approval recommendation for the drug.
No Comments »
Filed under: General Health News
Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People’s Republic of China today reported that its innovative asthma drug Laevo-Bambuterol has received approval from China’s State Food & Drug Administration’s (SFDA) to commence clinical trials (No.2010L01309 and 2010L01399).
No Comments »
Filed under: Pharmacy News
EnzymeRx, LLC, a clinical-stage biotechnology company, today announced top line results from its first clinical trial of pegsitacase (formerly called Uricase‑PEG 20). Pegsitacase is a pegylated uricase being developed by EnzymeRx for the treatment of refractory gout and for the management of hyperuricemia associated with tumor lysis syndrome.
No Comments »
Filed under: Pharmacy News
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that it has entered into an exclusive US $75 million license agreement with Kissei Pharmaceutical Co., Ltd. for the development and commercialization of its PSA-activated pro-drug, PRX302, in Japan for BPH, prostate cancer and other diseases of the prostate. Protox [...]
No Comments »
Filed under: Pharmacy News
Artisan Pharma, Inc., a private biopharmaceutical company dedicated to bringing best-in-class critical care therapeutics to patients, today announced the completion of patient enrollment in its Phase 2b study of ART-123 (Recomodulin® - recombinant human thrombomodulin) in sepsis patients with disseminated intravascular coagulation (DIC). The clinical trial was a randomized, double-blind, placebo-controlled Phase 2b study to [...]
No Comments »
Filed under: Pharmacy News
